Ryan K Dale Selected Research

Glycosphingolipids

11/2021

Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryan K Dale Research Topics

Disease

2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 01/2023 - 11/2021
2	Disease Progression 01/2023 - 01/2023
2	Lyme Disease (Disease, Lyme) 01/2023 - 01/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 11/2021
2	Melorheostosis 12/2022 - 01/2020
1	Developmental Bone Diseases (Bone Dysplasia) 01/2023
1	Bone Fractures (Bone Fracture) 01/2023
1	Gigantism 01/2023
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Congenital Abnormalities (Deformity) 01/2023

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2021
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2023
1	Complementary RNA (cRNA)IBA 01/2023
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2023
1	Superoxides (Superoxide)IBA 01/2023
1	CollagenIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 12/2022
1	CholesterolIBA 11/2021
1	GlycosphingolipidsIBA 11/2021
1	InterferonsIBA 01/2020

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2020